A Nobel Prize on the Shelf: Why Ivermectin Remains Underused for the Very Conditions It Was Approved to Treat
Ivermectin earned a share of the 2015 Nobel Prize in Physiology or Medicine and carries decades of clinical validation for specific parasitic infections — yet it remains surprisingly underutilized within the American healthcare system. Prescriber unfamiliarity, formulary gaps, and lingering misconceptions about the drug's safety record have combined to reduce access for patients who genuinely need it. This article examines the structural and perceptual barriers standing between a proven therapeu